Latest Antibiotic-resistant bacteria Stories
CDC report provides first snapshot of state efforts to prevent MRSA and deadly diarrheal infections ATLANTA, Jan.
GLASGOW, Scotland, January 12, 2015 /PRNewswire/ -- Highlights - In September 2014, MGB Biopharma secured GBP4M ($6.4M) from leading
-- On Schedule to Release Topline Data from Phase 1b Clinical Trial and to Start Phase 2 Clinical Trial of SYN-004 in 1Q 2015 -- ROCKVILLE, Md., Dec.
-- First-in-Class Drug Candidate to Prevent C. difficile Ahead of Schedule for Phase 2 Testing to Begin in 1st Quarter 2015 -- ROCKVILLE, Md., Dec.
Sophisticated lung imaging can reveal whether or not a treatment drug is able to clear tuberculosis (TB) lung infection in human and macaque parallel studies, according to University of Pittsburgh
-- First-in-Class Clinical Program Targets Protection of Microbiome to Prevent Overgrowth of Deadly C. difficile Infection Linked with Use of IV Antibiotics -- ROCKVILLE, Md., Dec.
Connecticut-based medical malpractice law firm, The Berkowitz Law Firm LLC, provides commentary on the topic. Stamford, CT (PRWEB) November 26, 2014
-- Phase 1a and 1b Trials to Use SYN-004 to Protect Microbiome; Intended to Prevent Overgrowth of Potentially Deadly C. difficile Bacteria -- ROCKVILLE, Md., Nov.
High-Use Areas Throughout Hospital Receive Healthy Makeover with Antimicrobial Copper Surfaces PULLMAN, Wash., Nov.
Unique Phenotypic Targeting Approach Provides Physicians with a Better, Faster Way to Identify MRSA and MSSA WOBURN, Mass., Nov.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.